FARGO, ND – Aldevron, a leading provider of products and contract manufacturing services for the pharmaceutical and biotechnology industries, today announced the appointment of James Brown, Ph.D., as Vice President, Corporate Development, effective immediately. Dr. Brown’s responsibilities will include developing and implementing strategies for expanding Aldevron’s DNA, mRNA, antibody, and protein products and production services.
“We are pleased to add James to our executive leadership team during this time of rapid growth for our company and industry,” said Michael Chambers, President and CEO of Aldevron. “James has more than 20 years’ experience in the biotechnology industry and has been a key player in the successful growth of several organizations. His broad background in partnership development, biologics manufacturing, vendor and client management, and operations will be invaluable as we focus on serving our clients in their efforts to develop the next generation of biological treatments for some of the most challenging diseases.”